NCT04253561
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04253561
Title Ipatasertib + Pertuzumab +Trastuzumab in Advanced HER2+ PI3KCA-mutant Breast Cancer Patients (IPATHER)
Acronym IPATHER
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors SOLTI Breast Cancer Research Group
Indications
Therapies
Age Groups: adult | senior
Covered Countries ESP

Facility Status City State Zip Country Details
ICO Badalona Badalona Barcelona Spain Details
Hospital Universitario del Vall d' Hebron Barcelona Barcelona Spain Details
Comp. Hosp.Univ. Santiago (Chus) Santiago de Compostela La Coruña Spain Details
H.Univ. Arnau de Vilanova de Lleida Lleida Lleida Spain Details
Centro Integral Oncológico Clara Campal (CIOCC) Madrid Madrid Spain Details
Hospital Universitario Doce de Octubre Madrid Madrid Spain Details
MD Anderson Madrid Madrid Spain Details
Hospital Universitario Virgen del Rocio Seville Sevilla Spain Details
Hospital Virgen de Macarena Seville Sevilla Spain Details
Fundación Instituto Valenciano de Oncología Valencia Valencia Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field